1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. LBX Pharmacy Chain Joint Stock Company
  6. News
  7. Summary
    603883   CNE1000023Q8

LBX PHARMACY CHAIN JOINT STOCK COMPANY

(603883)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-06-26
43.37 CNY   -1.16%
06/22Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
05/27UBS Adjusts LBX Pharmacy Chain's Price Target to 47.50 Yuan From 81.50 Yuan, Keeps at Buy
MT
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LBX Pharmacy Chain Joint Stock Company cancelled the acquisition of 51% stake in Hebei Hua Tuo Pharmacy Medicine Chain Co., Ltd. from Zhang Weijun, Tian Jinping, Ma Zhirong and Guo Zhihong.

03/06/2022 EDT

LBX Pharmacy Chain Joint Stock Company (SHSE:603883) agreed to acquire 51% stake in Hebei Hua Tuo Pharmacy Medicine Chain Co., Ltd. from Zhang Weijun, Tian Jinping, Ma Zhirong and Guo Zhihong for CNY 1.4 billion on August 24, 2021. Under the terms of consideration, The first advance payment: within 7 working days after this agreement is signed and effective, 20% of the total transfer price shall be paid, totaling CNY 285.6 million and The second transfer price: After the completion of the target company’s assets divestiture, the target equity change, the establishment of the target company’s board of directors, and the completion of the above work within seven working days, 40% of the total transfer price shall be paid, totaling CNY 571.2 million and The third transfer payment: 10% of the total transfer price shall be paid within 7 working days after the establishment of the board of directors, totaling CNY 142.8 million and The fourth transfer price: within 7 working days after the seller provides the personal income tax payment voucher, 10% of the total transfer price shall be paid, totaling CNY 142.8 million and The fifth transfer price: After auditing, evaluating and confirming that the net assets of the target company meet stipulated in this agreement on the delivery date, within 7 working days 10% of the total transfer price shall be paid, totaling RMB 142.8 million and The sixth transfer price: the amount of CNY 142.8 million yuan is the deposit, and the guarantee period is one year (calculated from the delivery date). After the expiration, the two parties confirm that the seller has no deductions for payment and shall pay within 7 working days. The consideration will be funded through its own funds. Hebei Hua Tuo Pharmacy Medicine Chain reported total assets of CNY 821.6 million and total common equity of CNY 227.7 million till April 31, 2021. LBX Pharmacy Chain Joint Stock Company's board approved the deal. LBX Pharmacy Chain Joint Stock Company (SHSE:603883) cancelled the acquisition of 51% stake in Hebei Hua Tuo Pharmacy Medicine Chain Co., Ltd. from Zhang Weijun, Tian Jinping, Ma Zhirong and Guo Zhihong on March 6, 2022. LBX Pharmacy Chain Joint Stock Company received a total of CNY 285.6 million in total repaid by the company from the seller on March 15, 2022.


© S&P Capital IQ 2022
All news about LBX PHARMACY CHAIN JOINT STOCK COMPANY
06/22Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
05/27UBS Adjusts LBX Pharmacy Chain's Price Target to 47.50 Yuan From 81.50 Yuan, Keeps at B..
MT
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended..
CI
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter E..
CI
03/07LBX Pharmacy Chain Joint Stock Company singed an Asset Purchase Agreement to acquire a ..
CI
03/06LBX Pharmacy Chain Joint Stock Company cancelled the acquisition of 51% stake in Hebei ..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake..
CI
2021LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months End..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of the remaining 35% s..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake..
CI
More news
Analyst Recommendations on LBX PHARMACY CHAIN JOINT STOCK COMPANY
More recommendations
Financials
Sales 2022 18 259 M 2 729 M 2 729 M
Net income 2022 780 M 117 M 117 M
Net Debt 2022 2 673 M 399 M 399 M
P/E ratio 2022 25,2x
Yield 2022 0,97%
Capitalization 19 322 M 2 888 M 2 888 M
EV / Sales 2022 1,20x
EV / Sales 2023 1,02x
Nbr of Employees -
Free-Float 43,9%
Chart LBX PHARMACY CHAIN JOINT STOCK COMPANY
Duration : Period :
LBX Pharmacy Chain Joint Stock Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LBX PHARMACY CHAIN JOINT STOCK COMPANY
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 43,37 CNY
Average target price 50,43 CNY
Spread / Average Target 16,3%
EPS Revisions
Managers and Directors
Li Wang President
Jing Yang Zhu Chief Financial Officer
Zi Long Xie Chairman
Cheng Xiang Wang Chairman-Supervisory Board
Zhe Min Dan Independent Director
Sector and Competitors